ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is Magnesium the Missing Link in Your Heart Healthy Routine?

A Little Zinc Goes a Long Way

Supplementation with vitamin D associated with improved testosterone, erectile function among middle...

More evidence for calorie restriction’s longevity effect

Vitamin D deficiency increases risk of chronic headache

Wearable biosensors can flag illness, Lyme disease, risk for diabetes; low airplane oxygen

VIDEO: The Best Brain Foods That Help Increase Your Memory!

Iron (And More) For Lasting, Natural Energy

Affordable Care Act made cancer screening more accessible for millions, study finds

Metabolic syndrome increases the need for vitamin E

 
Print Page
Email Article

Previous immunoglobulin therapy appears to cut Alzheimer’s risk - national treatment trial under way

  [ 27 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 25, 2009


“The current Alzheimer’s drugs on the market treat the symptoms of the disease. Immunization could treat the underlying cause.”

IVIg treatments - the addition of good antibodies into the blood stream - may hold promise for lowering the risk of Alzheimer’s disease and other similar brain disorders, according to research published in the July 21 issue of Neurology,(1) the medical journal of the American Academy of Neurology.

“In our study, we looked at the association of the use of intravenous immunoglobulin (IVIg) with the occurrence of Alzheimer’s disease. IVIg has been used safely for more than 20 years to treat other diseases but is thought to have an indirect effect on Alzheimer’s disease by targeting beta-amyloid, or plaques in the brain,” said Howard Fillit, MD, with the Mount Sinai School of Medicine in New York.

For the study, researchers analyzed the medical records of 847 people given at least one treatment of IVIg over four years and 84,700 who were not given IVIg treatment. Participants were treated for immune deficiencies, leukemia or other types of cancer, anemia and other diseases. The records were pulled from a database of 20 million patients age 65 or older developed by SDI Health. Scientists made sure the groups were similar in their risk factors for Alzheimer’s disease.

The study found that people who received IVIg for other conditions had a 42 percent lower risk of developing Alzheimer’s disease over four years compared to those who did not receive IVIg.

Only 2.8 percent of those treated with IVIg developed Alzheimer’s disease compared with 4.8 percent of those not treated with immune-based therapy.

“Our study provides evidence that previous IVIg treatments may protect against Alzheimer’s disease,” said Fillit. “The current Alzheimer’s drugs on the market treat the symptoms of the disease. Immunization could treat the underlying cause.”

33-center treatment trial now recruiting

“These findings do not constitute an endorsement of IVIg treatment for Alzheimer’s disease. A large scale clinical trial is underway to determine whether IVIg could be an effective treatment for Alzheimer’s,” researchers said.

[Note: For information about this trial, which is recruiting at 33 centers across the U.S., see ClinicalTrials.gov - “A Phase 3 study evaluating safety and effectiveness of IGIV for the treatment of mild to moderate Alzheimer’s disease.”

The study was supported by Baxter International Inc., a manufacturer of IVIg.
___
1. Article: “IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders”

Source: American Academy of Neurology news release, Jul 20, 2009




Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Mitochondria Ignite™ with NT Factor® Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Rejuvenating the Brain - How PQQ Helps Power Up Mental Processing Rejuvenating the Brain - How PQQ Helps Power Up Mental Processing
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map